Evidence map›Paper›PMID 33801883›Full record

ReviewNutrients2021

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases.

Yan Jiang, Karolin Jarr, Cosima Layton, Christopher D Gardner, Judith F Ashouri, Maria T Abreu, Sidhartha R Sinha

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05683730 (Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05683730 narecruitingnot on this mapstarted 2023, after this paper: background citation

Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease: A Randomized, Open-label, Controlled Trial

TypeinterventionalSponsorCentral Hospital, Nancy, FranceRan2023 to 2027Enrolled174ConditionsCrohn's DiseaseArmsIntermittent caloric restriction
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Vaccination therapy for inflammatory bowel disease.Human vaccines & immunotherapeutics · 2023
    Review
  19. γ-Glutamylcysteine rescues mice from TNBS-driven inflammatory bowel disease through regulating macrophages polarization.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yan JiangDivision of Gastroenterology & Hepatology, Department of Medicine, Stanford University, 300 Pasteur Drive, M211, Stanford, CA 94305, USA.
Karolin JarrDivision of Gastroenterology & Hepatology, Department of Medicine, Stanford University, 300 Pasteur Drive, M211, Stanford, CA 94305, USA.
Cosima LaytonUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Christopher D GardnerStanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA 94305, USA.
Judith F AshouriDivision of Rheumatology, Department of Medicine, University of California, San Francisco, CA 94143, USA.ORCID 0000-0001-8405-7503
Maria T AbreuDivision of Gastroenterology, Department of Medicine, Leonard Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Sidhartha R SinhaDivision of Gastroenterology & Hepatology, Department of Medicine, Stanford University, 300 Pasteur Drive, M211, Stanford, CA 94305, USA.ORCID 0000-0001-5104-6410
Stanford University · USUniversity of California, San Francisco · USUniversity of Miami · USUniversity of North Carolina at Chapel Hill · US

Funding

Signaling and repertoire differences in arthritogenic T cellsK08AR072144 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ASHOURI, JUDITH · 2018 to 2022
$887k
NIAMS NIH HHS K08 AR072144The Leona M. and Harry B. Helmsley Charitable Trust 2007-403 04026.
6 · The paper itself

Abstract

Despite being a focal issue to patients, the effect of diet on adult inflammatory bowel disease (IBD) remains underexplored with limited guidance. While promising clinical trials are currently underway, there is a need for further evidence-based recommendations. As such, we summarize the current evidence on various diets used in the treatment of IBD and also explore the potential applications of dietary data from related immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis and psoriasis, to provide additional information to inform IBD providers. To date, there have been multiple diets investigated as adjunctive therapy in IBD, but many associated studies are small, non-randomized, and not controlled. Mediterranean, vegetarian/vegan, and reduced-calorie/fasting diets have been studied and have shown some positive results in other IMIDs, which may suggest potential applicability to those with IBD, but larger, well-designed clinical trials are needed for further guidance. Gluten-free and low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP)diets do not appear to have an impact on IBD disease activity, but low FODMAP may potentially be helpful for those with concurrent functional gastrointestinal symptoms. Specific carbohydrate diets have been mainly assessed in children but show some potential in small adult studies.

Indexed as

DietArthritis, RheumatoidCaloric RestrictionDiet, Carbohydrate-RestrictedDiet, Gluten-FreeDiet, High-Protein Low-CarbohydrateDiet, MediterraneanDiet, PaleolithicDiet, VeganDiet, VegetarianFastingHumansInflammatory Bowel DiseasesPsoriasisCrohn’s diseasedietinflammatory bowel diseasesulcerative colitis

Identifiers

PMID33801883
PMCPMC8001318
OpenAlexW3134002069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.